Delivery Order SPE2D018D0006-SPE2D325F6935
Award Date
2/25/25
Potential Completion Date
2/28/25
Potential Value
$5.3K
Federal Agency
Medical Supply Chain
Awardee
Eagle Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Westwood, NJ 07677, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract, valued at $5,080.62, is for the supply of 250mg vials of the drug Ryanodex, which is used to treat and prevent malignant hyperthermia in high-risk patients. This delivery order contract is not set aside and is part of a larger Federal Supply Schedule (FSS) contract between Eagle...
The U.S. government, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a delivery order contract to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, for the supply of the drug Ryanodex. The contract has a ceiling value of $132,251.39 and an ultimate completion date of April 8, 2024. Ryanodex is a critical medication used for the treatment and prevention of malignant hyperthermia in high-risk patients, primarily for military healthcare operations....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc. for the supply of Ryanodex, a 250mg injectable medication used for the treatment and prevention of malignant hyperthermia. The contract has a ceiling value of $10,161.24 and is a firm fixed price delivery order that runs through August 2024. Eagle Pharmaceuticals is a specialized pharmaceutical company that provides critical medications to the U.S. federal...
This is a firm fixed-price delivery order contract (SPE2D018D0006|SPE2D325F4806) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, for the supply of Ryanodex (250 mg vials), a drug used to treat and prevent malignant hyperthermia. The contract has a ceiling value of $10,585.32 and an ultimate completion date of January 29, 2025. This award is not associated with a set-aside program. Eagle...
The federal contract award SPE2D018D0006|SPE2D021F0173 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Eagle Pharmaceuticals, Inc. The $87,282.92 firm fixed-price delivery order contract is for the provision of other medical supplies, specifically the 250mg injectable medication Ryanodex, used to treat and prevent malignant hyperthermia in high-risk patients. This contract does not have a set-aside designation, indicating Eagle Pharmaceuticals...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract is for the supply of Ryanodex, a 250mg injectable medication used to treat and prevent malignant hyperthermia in high-risk patients. The contract has a ceiling value of $5,080.62 and an ultimate completion date of December 10, 2024. This contract is not associated with any set-aside...
Eagle Pharmaceuticals, Inc. has been awarded a $4,874.13 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to supply 250mg vials of the drug Ryanodex. As the prime contractor, Eagle Pharmaceuticals will deliver the specified pharmaceutical products to DLA Troop Support Medical's place of performance in Westwood, New Jersey by November 15, 2023. No major subcontractors or joint venture partners are involved. The delivery order was...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,283.20, is for the delivery of Ryanodex 250 mg vials, a specialty medication, to support military and government medical programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Ryanodex 250 mg vials. The contract has a ceiling value of $3,962.40 and an ultimate completion date of November 23, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 250 mg vials of the drug Ryanodex. The delivery order is valued at $5,958.56 and has a period of performance through November 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the agency to efficiently...